³ÉÈË¿ìÊÖ

1. Decision on taking business in private:

The Committee agreed to take item 5 in private.

The Committee agreed to take the next meetings on 28 February and 7 March 2023 in private.

2. Patient Safety Commissioner for Scotland Bill:

The Committee took evidence on the Bill at Stage 1 from—

Dr Amit Aggarwal, Executive Director, Medical Affairs, The Association of the British Pharmaceutical Industry;

Shaun Gallagher, Director of Strategy and Policy, General Medical Council;

Matthew McClelland, Executive Director of Strategy and Insight, Nursing and Midwifery Council;

Richard Phillips, Director of Strategy, The Association of British HealthTech Industries;

Dr Chris Williams, Joint Chair, Royal College of General Practitioners Scotland;

and then from—

Dr Henrietta Hughes, Patient Safety Commissioner for England and Dr Gary Duncan, Chief of Staff to the Patient Safety Commissioner.

3. Public petitions:

The Committee considered the following petitions—
[PE01845] Agency to advocate for the healthcare needs of rural Scotland; [PE01890] Find solutions to recruitment and training challenges for rural healthcare in Scotland: The Committee agreed to close the petitions under Rule 15.7 of Standing Orders on the basis that the Committee would consider the issues raised in them as part of a broader inquiry into remote and rural healthcare, to be considered as part of its future work programme. 
[PE01924] Complete an emergency in-depth review of Women's Health services in Caithness & Sutherland: The Committee agreed to defer further consideration of the petition until after the Best Start North Review has concluded.

4. Subordinate legislation:

The Committee considered the following negative instruments—


The Committee agreed to make no recommendations in relation to the instruments.

5. Patient Safety Commissioner for Scotland Bill:

The Committee considered the evidence it heard earlier under agenda item 2.